MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma

(2015) Somnath Mukherjee et al.   BMC CANCER

Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer

(2014) Joel Shapiro et al.   ANNALS OF SURGERY

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma

(2014) Heath D. Skinner et al.   CANCER

Role of Chemoradiotherapy in Oesophageal Cancer — Adjuvant and Neoadjuvant Therapy

(2014) S. Gwynne et al.   CLINICAL ONCOLOGY

Discovery and characterization of miRNA during cellular senescence in bone marrow-derived human mesenchymal stem cells

(2014) Jung Ki Yoo et al.   EXPERIMENTAL GERONTOLOGY

Global incidence of oesophageal cancer by histological subtype in 2012

(2014) Melina Arnold et al.   GUT

MiR-330-Mediated Regulation of SH3GL2 Expression Enhances Malignant Behaviors of Glioblastoma Stem Cells by Activating ERK and PI3K/AKT Signaling Pathways

(2014) Yilong Yao et al.   PLoS One

miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42

(2013) Yuefeng Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Oesophageal Chemoradiotherapy in the UK—Current Practice and Future Directions

(2013) S. Gwynne et al.   CLINICAL ONCOLOGY

A review of the current understanding and clinical utility of miRNAs in esophageal cancer

(2013) Naomi S. Sakai et al.   SEMINARS IN CANCER BIOLOGY

MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma

(2012) Niamh Lynam-Lennon et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene

(2012) Shengtao Qu et al.   PLoS One

Radiation Sensitivity of Esophageal Adenocarcinoma: The Contribution of the RNA-Binding Protein RNPC1 and p21-Mediated Cell Cycle Arrest to Radioresistance

(2012) Gijsbert J. Hötte et al.   RADIATION RESEARCH

Targeting of mRNAs by multiple miRNAs: the next step

(2010) M E Peter   ONCOGENE

Alterations in DNA Repair Efficiency are Involved in the Radioresistance of Esophageal Adenocarcinoma

(2010) Niamh Lynam-Lennon et al.   RADIATION RESEARCH

Gene Expression Analysis of Diagnostic Biopsies Predicts Pathological Response to Neoadjuvant Chemoradiotherapy of Esophageal Cancer

(2009) Stephen G. Maher et al.   ANNALS OF SURGERY

MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types

(2009) Richard Hummel et al.   EUROPEAN JOURNAL OF CANCER

Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

(2009) William H. Allum et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

(2009) Michael Stahl et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

(2009) K-H Lee et al.   ONCOGENE